INMUNE BIO INC. Operating Lease, Expense
INMUNE BIO INC. (INMB) reported Operating Lease, Expense of $206.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-06
- INMUNE BIO INC. operating lease, expense for the quarter ending 2026-06-30 was $206.00M, a 274.55% increase year-over-year.
- INMUNE BIO INC. operating lease, expense for the quarter ending 2026-03-31 was $147.00M, a 376823.08% increase year-over-year.
- INMUNE BIO INC. operating lease, expense for the quarter ending 2025-12-31 was $39.77M, a 96902.44% increase year-over-year.
- INMUNE BIO INC. operating lease, expense for the quarter ending 2025-09-30 was $134.00K, a 235.00% increase year-over-year.
- INMUNE BIO INC. operating lease, expense for fiscal 2024 was $161.00K, a 1.23% decline from fiscal 2023.
- INMUNE BIO INC. operating lease, expense for fiscal 2023 was $163.00K, a 22.01% decline from fiscal 2022.
- INMUNE BIO INC. operating lease, expense for fiscal 2022 was $209.00K, a 104.90% increase from fiscal 2021.
- INMUNE BIO INC. operating lease, expense for fiscal 2021 was $102.00K.
| Period end | Operating Lease, Expense 1 month | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $206.00M 10-Q · filed 2026-08-06 | $353.00M 10-Q · filed 2026-08-06 | $392.77M derived: sum of 3 quarters · filed 2026-08-06 | $392.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $147.00M 10-Q · filed 2026-05-07 | $186.77M derived: sum of 2 quarters · filed 2026-05-07 | $186.91M derived: sum of 3 quarters · filed 2026-05-07 | $241.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $39.77M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-07 | $39.91M derived: sum of 2 quarters · filed 2026-05-07 | $94.91M derived: sum of 3 quarters · filed 2026-08-06 | $40.00M 10-Q · filed 2026-05-07 | $381.00K 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $134.00K 10-Q · filed 2025-10-30 | $55.13M derived: sum of 2 quarters · filed 2026-08-06 | $229.00K 10-Q · filed 2025-10-30 | $55.21M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $55.00M 10-Q · filed 2026-08-06 | $55.00K 10-Q · filed 2025-08-07 | $95.00M 10-Q · filed 2026-08-06 | $95.00K 10-Q · filed 2025-08-07 | $55.08M derived: sum of 3 quarters · filed 2026-08-06 | $55.12M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $39.00K 10-Q · filed 2025-05-08 | $80.00K derived: sum of 2 quarters · filed 2026-03-30 | $120.00K derived: sum of 3 quarters · filed 2026-03-30 | $161.00K derived: sum of 4 quarters · filed 2026-03-30 | ||||
| 2024-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $81.00K derived: sum of 2 quarters · filed 2026-03-30 | $122.00K derived: sum of 3 quarters · filed 2026-03-30 | $161.00K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $40.00K 10-Q · filed 2025-10-30 | $81.00K derived: sum of 2 quarters · filed 2025-10-30 | $120.00K 10-Q · filed 2025-10-30 | $160.00K derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | $41.00K 10-Q · filed 2025-08-07 | $80.00K 10-Q · filed 2025-08-07 | $120.00K derived: sum of 3 quarters · filed 2025-08-07 | $161.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $39.00K 10-Q · filed 2024-05-09 | $79.00K derived: sum of 2 quarters · filed 2025-03-27 | $120.00K derived: sum of 3 quarters · filed 2025-03-27 | $159.00K derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2023-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $81.00K derived: sum of 2 quarters · filed 2025-03-27 | $120.00K derived: sum of 3 quarters · filed 2025-03-27 | $163.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $41.00K 10-Q · filed 2024-10-31 | $80.00K derived: sum of 2 quarters · filed 2024-10-31 | $123.00K 10-Q · filed 2024-10-31 | $170.00K derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | $39.00K 10-Q · filed 2024-08-01 | $82.00K 10-Q · filed 2024-08-01 | $129.00K derived: sum of 3 quarters · filed 2024-08-01 | $174.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | $43.00K 10-Q · filed 2024-05-09 | $90.00K derived: sum of 2 quarters · filed 2024-05-09 | $135.00K derived: sum of 3 quarters · filed 2024-05-09 | $189.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $92.00K derived: sum of 2 quarters · filed 2024-03-28 | $146.00K derived: sum of 3 quarters · filed 2024-03-28 | $209.00K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $45.00K 10-Q · filed 2023-11-01 | $99.00K derived: sum of 2 quarters · filed 2023-11-01 | $162.00K 10-Q · filed 2023-11-01 | $210.00K derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-06-30 | $54.00K 10-Q · filed 2023-08-07 | $108.00K 10-Q · filed 2023-08-07 | $165.00K derived: sum of 3 quarters · filed 2023-08-07 | $184.00K derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $54.00K 10-Q · filed 2022-05-05 | $111.00K derived: sum of 2 quarters · filed 2023-03-02 | $130.00K derived: sum of 3 quarters · filed 2023-03-02 | $143.00K derived: sum of 4 quarters · filed 2023-03-02 | ||||
| 2021-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $76.00K derived: sum of 2 quarters · filed 2023-03-02 | $89.00K derived: sum of 3 quarters · filed 2023-03-02 | $102.00K 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $19.00K 10-Q · filed 2021-11-03 | $32.00K derived: sum of 2 quarters · filed 2021-11-03 | $45.00K 10-Q · filed 2022-11-02 | |||||
| 2021-06-30 | $13.00K 10-Q · filed 2021-08-04 | $26.00K 10-Q · filed 2022-08-03 | ||||||
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | $52.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |